Trump order may see innovative drug prices getting halved, impact generic cos: Nirmal Bang Securities
Safety and pricing biggest US concern on Trump pharma order, says Vishal Manchanda, Equity Research Analyst — Pharma. The Trump administration has unveiled executive orders to curb drug prices. We understand four of them have been signed. This will mostly be on capping drug prices. This is not the first time that we have come … Read more
